MTOR and histiocytic sarcoma: Insulin and insulin-like growth factor 1 (IGF-1) lead to the activation of mammalian target of rapamycin (mTOR), whose expression was found to be increased in both the lesional and non-lesional skin of HS patients compared to the normal skin of healthy controls, with a strong correlation to disease severity [94,213,214].